ABOUT THE COMPANY

Helus Pharma (NASDAQ: HELP) is a late-stage neuropsychiatry company dedicated to revolutionizing mental healthcare. Through the development of innovative next-generation therapeutics, Helus Pharma aims to address the significant unmet needs of people affected by depression, anxiety, and other mental health conditions. Founded in 2019, the company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

With pr...